相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A meta-analysis of reversion mutations in BRCA genes identifies signatures of DNA end-joining repair mechanisms driving therapy resistance
L. Tobalina et al.
ANNALS OF ONCOLOGY (2021)
Regulation of DNA double-strand break repair pathway choice: a new focus on 53BP1
Fan Zhang et al.
JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B (2021)
BRCA mutated pancreatic cancer: A change is coming
Michael N. Rosen et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Germline Mutations in Other Homologous Recombination Repair-Related Genes Than BRCA1/2: Predictive or Prognostic Factors?
Laura Cortesi et al.
JOURNAL OF PERSONALIZED MEDICINE (2021)
Structural basis of homologous recombination
Yueru Sun et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
PALB2 chromatin recruitment restores homologous recombination in BRCA1-deficient cells depleted of 53BP1
Rimma Belotserkovskaya et al.
NATURE COMMUNICATIONS (2020)
Physiological expression and function of the MDR1 transporter in cytotoxic T lymphocytes
Mei Lan Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Olaparib for Metastatic Castration-Resistant Prostate Cancer
J. de Bono et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Combined PARP and ATR inhibition potentiates genome instability and cell death in ATM-deficient cancer cells
Rebecca L. Lloyd et al.
ONCOGENE (2020)
Combining PARP with ATR inhibition overcomes PARP inhibitor and platinum resistance in ovarian cancer models
Hyoung Kim et al.
NATURE COMMUNICATIONS (2020)
Phase I Trial of the PARP Inhibitor Olaparib and AKT Inhibitor Capivasertib in Patients with BRCA1/2- and Non-BRCA1/2-Mutant Cancers
Timothy A. Yap et al.
CANCER DISCOVERY (2020)
The chromatin remodeler ALC1 underlies resistance to PARP inhibitor treatment
Szilvia Juhasz et al.
SCIENCE ADVANCES (2020)
Isomerization of BRCA1-BARD1 promotes replication fork protection
Manuel Daza-Martin et al.
NATURE (2019)
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer
Talia Golan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
A systematic review of the international prevalence of BRCA mutation in breast cancer
Nigel Armstrong et al.
CLINICAL EPIDEMIOLOGY (2019)
The F-Box Domain-Dependent Activity of EMI1 Regulates PARPi Sensitivity in Triple-Negative Breast Cancers
Antonio Marzio et al.
MOLECULAR CELL (2019)
The Tumor Suppressor PALB2: Inside Out
Mandy Ducy et al.
TRENDS IN BIOCHEMICAL SCIENCES (2019)
ATM orchestrates the DNA-damage response to counter toxic non-homologous end-joining at broken replication forks
Gabriel Balmus et al.
NATURE COMMUNICATIONS (2019)
BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
Yifan Wang et al.
NATURE COMMUNICATIONS (2019)
Tumour heterogeneity and resistance to cancer therapies
Ibiayi Dagogo-Jack et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer
C. Cruz et al.
ANNALS OF ONCOLOGY (2018)
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality
Ewa Gogola et al.
CANCER CELL (2018)
DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity
Rajat Gupta et al.
CELL (2018)
Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance
Stephen J. Pettitt et al.
NATURE COMMUNICATIONS (2018)
Defective Replication Stress Response Is Inherently Linked to the Cancer Stem Cell Phenotype
Daniel J. McGrail et al.
CELL REPORTS (2018)
Mechanisms for stalled replication fork stabilization: new targets for synthetic lethality strategies in cancer treatments
Hongwei Liao et al.
EMBO REPORTS (2018)
Comprehensive Mapping of Histone Modifications at DNA Double-Strand Breaks Deciphers Repair Pathway Chromatin Signatures
Thomas Clouaire et al.
MOLECULAR CELL (2018)
The shieldin complex mediates 53BP1-dependent DNA repair
Sylvie M. Noordermeer et al.
NATURE (2018)
A RAD51 assay feasible in routine tumor samples calls PARP inhibitor response beyond BRCA mutation
Marta Castroviejo-Bermejo et al.
EMBO MOLECULAR MEDICINE (2018)
DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells
Yizhou Joseph He et al.
NATURE (2018)
The ASCIZ-DYNLL1 axis promotes 53BP1-dependent non-homologous end joining and PARP inhibitor sensitivity
Jordan R. Becker et al.
NATURE COMMUNICATIONS (2018)
RAD51 Mediates Resistance of Cancer Stem Cells to PARP Inhibition in Triple-Negative Breast Cancer
Yajing Liu et al.
CLINICAL CANCER RESEARCH (2017)
Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib
Aiste McCormick et al.
CLINICAL CANCER RESEARCH (2017)
Single-Molecule Imaging Reveals How Mre11-Rad50-Nbs1 Initiates DNA Break Repair
Logan R. Myler et al.
MOLECULAR CELL (2017)
Restoration of Replication Fork Stability in BRCA1-and BRCA2-Deficient Cells by Inactivation of SNF2-Family Fork Remodelers
Angelo Taglialatela et al.
MOLECULAR CELL (2017)
RADX Promotes Genome Stability and Modulates Chemosensitivity by Regulating RAD51 at Replication Forks
Huzefa Dungrawala et al.
MOLECULAR CELL (2017)
Smarcal1-Mediated Fork Reversal Triggers Mre11-Dependent Degradation of Nascent DNA in the Absence of Brca2 and Stable Rad51 Nucleofilaments
Arun Mouli Kolinjivadi et al.
MOLECULAR CELL (2017)
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Andrew N. Blackford et al.
MOLECULAR CELL (2017)
The control of DNA repair by the cell cycle
Nicole Hustedt et al.
NATURE CELL BIOLOGY (2017)
PARP inhibitors: Synthetic lethality in the clinic
Christopher J. Lord et al.
SCIENCE (2017)
MRE11 and EXO1 nucleases degrade reversed forks and elicit MUS81-dependent fork rescue in BRCA2-deficient cells
Delphine Lemacon et al.
NATURE COMMUNICATIONS (2017)
Replication fork reversal triggers fork degradation in BRCA2-defective cells
Sofija Mijic et al.
NATURE COMMUNICATIONS (2017)
Secondary Somatic Mutations Restoring RAD51C and RAD51D Associated with Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Olga Kondrashova et al.
CANCER DISCOVERY (2017)
DNA-PKcs and PARP1 Bind to Unresected Stalled DNA Replication Forks Where They Recruit XRCC1 to Mediate Repair
Songmin Ying et al.
CANCER RESEARCH (2016)
ABCB1 (MDR1) induction defines a common resistance mechanism in paclitaxel- and olaparib-resistant ovarian cancer cells
Aparajitha Vaidyanathan et al.
BRITISH JOURNAL OF CANCER (2016)
The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin
Yifan Wang et al.
CANCER RESEARCH (2016)
Mechanism and regulation of DNA end resection in eukaryotes
Lorraine S. Symington
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1
Rinske Drost et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
Petra ter Brugge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Replication fork stability confers chemoresistance in BRCA-deficient cells
Arnab Ray Chaudhuri et al.
NATURE (2016)
FANCD2 limits replication stress and genome instability in cells lacking BRCA2
Johanna Michl et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer
C. C. Pritchard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Repair Pathway Choices and Consequences at the Double-Strand Break
Raphael Ceccaldi et al.
TRENDS IN CELL BIOLOGY (2016)
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
Xia Ding et al.
NATURE COMMUNICATIONS (2016)
Coordinated nuclease activities counteract Ku at single-ended DNA double-strand breaks
Pauline Chanut et al.
NATURE COMMUNICATIONS (2016)
FANCD2 limits replication stress and genome instability in cells lacking BRCA2
Johanna Michl et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
FANCD2 Maintains Fork Stability in BRCA1/2-Deficient Tumors and Promotes Alternative End-Joining DNA Repair
Zeina Kais et al.
CELL REPORTS (2016)
Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer
Petra ter Brugge et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Rif1: A Conserved Regulator of DNA Replication and Repair Hijacked by Telomeres in Yeasts
Stefano Mattarocci et al.
FRONTIERS IN GENETICS (2016)
Preventing replication fork collapse to maintain genome integrity
David Cortez
DNA REPAIR (2015)
The rise and fall of poly(ADP-ribose): An enzymatic perspective
John M. Pascal et al.
DNA REPAIR (2015)
The modulation of ABC transporter-mediated multidrug resistance in cancer: A review of the past decade
Rishil J. Kathawala et al.
DRUG RESISTANCE UPDATES (2015)
DNA2 drives processing and restart of reversed replication forks in human cells
Saravanabhavan Thangavel et al.
JOURNAL OF CELL BIOLOGY (2015)
Structural Basis of Detection and Signaling of DNA Single-Strand Breaks by Human PARP-1
Sebastian Eustermann et al.
MOLECULAR CELL (2015)
PARP-1 Activation Requires Local Unfolding of an Autoinhibitory Domain
Jennine M. Dawicki-McKenna et al.
MOLECULAR CELL (2015)
MAD2L2 controls DNA repair at telomeres and DNA breaks by inhibiting 5′ end resection
Vera Boersma et al.
NATURE (2015)
Homologous-recombination-deficient tumours are dependent on Polθ-mediated repair
Raphael Ceccaldi et al.
NATURE (2015)
Mammalian polymerase θ promotes alternative NHEJ and suppresses recombination
Pedro A. Mateos-Gomez et al.
NATURE (2015)
Whole-genome characterization of chemoresistant ovarian cancer
Ann-Marie Patch et al.
NATURE (2015)
REV7 counteracts DNA double-strand break resection and affects PARP inhibition
Guotai Xu et al.
NATURE (2015)
Homologous Recombination and Human Health: The Roles of BRCA1, BRCA2, and Associated Proteins
Rohit Prakash et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2015)
Cell cycle-dependent inhibition of 53BP1 signaling by BRCA1
Lin Feng et al.
CELL DISCOVERY (2015)
BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance
Janneke E. Jaspers et al.
CANCER RESEARCH (2015)
RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway
Tae Moon Kim et al.
NUCLEIC ACIDS RESEARCH (2015)
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas
Kathryn P. Pennington et al.
CLINICAL CANCER RESEARCH (2014)
Phosphorylated RPA recruits PALB2 to stalled DNA replication forks to facilitate fork recovery
Anar K. Murphy et al.
JOURNAL OF CELL BIOLOGY (2014)
53BP1, BRCA1, and the Choice between Recombination and End Joining at DNA Double-Strand Breaks
James M. Daley et al.
MOLECULAR AND CELLULAR BIOLOGY (2014)
Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib
Junko Murai et al.
MOLECULAR CANCER THERAPEUTICS (2014)
Connection between tumor suppressor BRCA1 and PTEN in damaged DNA repair
Akari Minami et al.
FRONTIERS IN ONCOLOGY (2014)
Function of BRCA1 in the DNA Damage Response Is Mediated by ADP-Ribosylation
Mo Li et al.
CANCER CELL (2013)
Inhibition of constitutively activated phosphoinositide 3-kinase/AKT pathway enhances antitumor activity of chemotherapeutic agents in breast cancer susceptibility gene 1-defective breast cancer cells
Yong Weon Yi et al.
MOLECULAR CARCINOGENESIS (2013)
A Genetic Screen Using the PiggyBac Transposon in Haploid Cells Identifies Parp1 as a Mediator of Olaparib Toxicity
Stephen J. Pettitt et al.
PLOS ONE (2013)
Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance
Neil Johnson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Distinct Replication Fork Protection Pathway Connects Fanconi Anemia Tumor Suppressors to RAD51-BRCA1/2
Katharina Schlacher et al.
CANCER CELL (2012)
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
Junko Murai et al.
CANCER RESEARCH (2012)
Mre11-Dependent Degradation of Stalled DNA Replication Forks Is Prevented by BRCA2 and PARP1
Songmin Ying et al.
CANCER RESEARCH (2012)
BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
Kathryn Alsop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Playing the End Game: DNA Double-Strand Break Repair Pathway Choice
J. Ross Chapman et al.
MOLECULAR CELL (2012)
The DNA damage response and cancer therapy
Christopher J. Lord et al.
NATURE (2012)
Mre11 regulates CtIP-dependent double-strand break repair by interaction with CDK2
Jeffrey Buis et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2012)
Distinct roles for DNA-PK, ATM and ATR in RPA phosphorylation and checkpoint activation in response to replication stress
Shengqin Liu et al.
NUCLEIC ACIDS RESEARCH (2012)
Structural Basis for DNA Damage-Dependent Poly(ADP-ribosyl)ation by Human PARP-1
Marie-France Langelier et al.
SCIENCE (2012)
BRCA1 negatively regulates IGF-1 expression through an estrogen-responsive element-like site
H. J. Kang et al.
CELL DEATH & DISEASE (2012)
Combining a PI3K Inhibitor with a PARP Inhibitor Provides an Effective Therapy for BRCA1-Related Breast Cancer
Ashish Juvekar et al.
CANCER DISCOVERY (2012)
Double-Strand Break Repair-Independent Role for BRCA2 in Blocking Stalled Replication Fork Degradation by MRE11
Katharina Schlacher et al.
CELL (2011)
Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer
Shiyu Zhang et al.
GYNECOLOGIC ONCOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
Nonhomologous end joining drives poly(ADP-ribose) polymerase (PARP) inhibitor lethality in homologous recombination-deficient cells
Anand G. Patel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Novel Agents and Future Directions for Refractory Breast Cancer
Harold J. Burstein
SEMINARS IN ONCOLOGY (2011)
PTEN loss in the continuum of common cancers, rare syndromes and mouse models
M. Christine Hollander et al.
NATURE REVIEWS CANCER (2011)
BRCA1-IRIS Overexpression Promotes Cisplatin Resistance in Ovarian Cancer Cells
Kerri L. Chock et al.
CANCER RESEARCH (2010)
PTEN Loss Compromises Homologous Recombination Repair in Astrocytes: Implications for Glioblastoma Therapy with Temozolomide or Poly(ADP-Ribose) Polymerase Inhibitors
Brian McEllin et al.
CANCER RESEARCH (2010)
Comprehensive Analysis of Missense Variations in the BRCT Domain of BRCA1 by Structural and Functional Assays
Megan S. Lee et al.
CANCER RESEARCH (2010)
Aberrant methylation of breast and ovarian cancer susceptibility gene 1 in chemosensitive human ovarian cancer cells does not involve the phosphatidylinositol 3'-kinase-Akt pathway
Yan-Qiu Wang et al.
CANCER SCIENCE (2010)
The PKB/AKT Pathway in Cancer
Amancio Carnero
CURRENT PHARMACEUTICAL DESIGN (2010)
BRCA1 CpG Island Hypermethylation Predicts Sensitivity to Poly(Adenosine Diphosphate)-Ribose Polymerase Inhibitors
Jurgen Veeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
AKT regulates BRCA1 stability in response to hormone signaling
Andrew C. Nelson et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2010)
PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
Konstantin J. Dedes et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination
Helen E. Bryant et al.
EMBO JOURNAL (2009)
Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors
Ana M. Mendes-Pereira et al.
EMBO MOLECULAR MEDICINE (2009)
Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler
Aaron J. Gottschalk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
PALB2 is an integral component of the BRCA complex required for homologous recombination repair
Shirley M. H. Sy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Poly(ADP-ribose)-Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1
Dragana Ahel et al.
SCIENCE (2009)
Negative Regulation of AKT Activation by BRCA1
Tao Xiang et al.
CANCER RESEARCH (2008)
The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications
Amancio Carnero et al.
CURRENT CANCER DRUG TARGETS (2008)
BRCA1 - sowing the seeds crooked in the furrow
William D. Foulkes
NATURE GENETICS (2008)
High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs
Sven Rottenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma
Ning-Fang Ma et al.
HEPATOLOGY (2008)
PARP1-dependent kinetics of recruitment of MRE11 and NBS1 proteins to multiple DNA damage sites
Jean-Francois Haince et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair
Lao H. Saal et al.
NATURE GENETICS (2008)
Feedback-regulated poly(ADP-ribosyl)ation by PARP-1 is required for rapid response to DNA damage in living cells
Oliver Mortusewicz et al.
NUCLEIC ACIDS RESEARCH (2007)
Characterisation of the sites of DNA damage-induced 53BP1 phosphorylation catalysed by ATM and ATR
Paul Jowsey et al.
DNA REPAIR (2007)
Ataxia telangiectasia mutated (ATM) signaling network is modulated by a novel poly(ADP-ribose)-dependent pathway in the early response to DNA-damaging agents
Jean-Francois Haince et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Essential role for nuclear PTEN in maintaining chromosomal integrity
Wen Hong Shen et al.
CELL (2007)
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints
Jirina Bartkova et al.
NATURE (2006)
Regional activation of chromosomal arm 7q with and without gene amplification in taxane-selected human ovarian cancer cell lines
YC Wang et al.
GENES CHROMOSOMES & CANCER (2006)
TopBP1 activates the ATR-ATRIP complex
A Kumagai et al.
CELL (2006)
Targeting multidrug resistance in cancer
G Szakács et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
The 8-kDa dynein light chain binds to p53-binding protein 1 and mediates DNA damage-induced p53 nuclear accumulation
KWH Lo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Direct activation of the ATM protein kinase by the Mre11/Rad50/Nbs1 complex
JH Lee et al.
SCIENCE (2004)
Replication Protein A phosphorylation and the cellular response to DNA damage
SK Binz et al.
DNA REPAIR (2004)
Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations
RS Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A requirement for PARP-1 for the assembly or stability of XRCC1 nuclear foci at sites of oxidative DNA damage
SF El-Khamisy et al.
NUCLEIC ACIDS RESEARCH (2003)
Structural consequences of a cancer-causing BRCA1-BRCT missense mutation
RS Williams et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Rad52 protein associates with replication protein a (RPA)-single-stranded DNA to accelerate Rad51-mediated displacement of RPA and presynaptic complex formation
T Sugiyama et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
分享论文
